These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9616710)

  • 21. Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation.
    Zignani M; Le Minh T; Einmahl S; Tabatabay C; Heller J; Anderson JM; Gurny R
    Biomaterials; 2000 Sep; 21(17):1773-8. PubMed ID: 10905459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a drug delivery system for the treatment of periodontal disease based on bioerodible poly(ortho esters).
    Roskos KV; Fritzinger BK; Rao SS; Armitage GC; Heller J
    Biomaterials; 1995 Mar; 16(4):313-7. PubMed ID: 7772671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microparticle Drug Delivery in Ophthalmology.
    Jastrzembski BG; Shah AS
    Int Ophthalmol Clin; 2017; 57(4):129-136. PubMed ID: 28885252
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel biodegradable blend matrices for controlled drug release.
    Lin M; Meng S; Zhong W; Li Z; Du Q; Tomasik P
    J Pharm Sci; 2008 Oct; 97(10):4240-8. PubMed ID: 18271038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facile synthesis of acid-labile polymers with pendent ortho esters.
    Cheng J; Ji R; Gao SJ; Du FS; Li ZC
    Biomacromolecules; 2012 Jan; 13(1):173-9. PubMed ID: 22176024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil.
    Chen W; Wu Z; Yang H; Guo S; Li D; Cheng L
    Pharm Dev Technol; 2014 Mar; 19(2):223-31. PubMed ID: 23432601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled release of protein from biodegradable multi-sensitive injectable poly(ether-urethane) hydrogel.
    Li X; Wang Y; Chen J; Wang Y; Ma J; Wu G
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3640-7. PubMed ID: 24460175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
    Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
    J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit.
    Trope GE; Cheng YL; Sheardown H; Liu GS; Menon IA; Heathcote JG; Rootman DS; Chiu WJ; Gould L
    Can J Ophthalmol; 1994 Dec; 29(6):263-7. PubMed ID: 7834564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colon cancer targeting using conjugates biomaterial 5-flurouracil.
    Jaferian S; Negahdari B; Eatemadi A
    Biomed Pharmacother; 2016 Dec; 84():780-788. PubMed ID: 27721176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression.
    Yi HG; Choi YJ; Kang KS; Hong JM; Pati RG; Park MN; Shim IK; Lee CM; Kim SC; Cho DW
    J Control Release; 2016 Sep; 238():231-241. PubMed ID: 27288878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of doxycycline-eluting delivery systems based on SynBiosys biodegradable multi-block copolymers.
    Gillissen M; Steendam R; van der Laan A; Tijsma E
    J Control Release; 2006 Nov; 116(2):e90-2. PubMed ID: 17718990
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigating a new drug delivery nano composite membrane system based on PVA/PCL and PVA/HA(PEG) for the controlled release of biopharmaceuticals for bone infections.
    Wan T; Stylios GK; Giannoudi M; Giannoudis PV
    Injury; 2015 Dec; 46 Suppl 8():S39-43. PubMed ID: 26747917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.
    Ortiz R; Cabeza L; Arias JL; Melguizo C; Álvarez PJ; Vélez C; Clares B; Áranega A; Prados J
    AAPS J; 2015 Jul; 17(4):918-29. PubMed ID: 25894746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatible Reduction and pH Dual-Responsive Core Cross-Linked Micelles Based on Multifunctional Amphiphilic Linear-Hyperbranched Copolymer for Controlled Anticancer Drug Delivery.
    Tian K; Jia X; Zhao X; Liu P
    Mol Pharm; 2017 Mar; 14(3):799-807. PubMed ID: 28186770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of biodegradable nanoparticles for liver-specific ribavirin delivery.
    Ishihara T; Kaneko K; Ishihara T; Mizushima T
    J Pharm Sci; 2014 Dec; 103(12):4005-4011. PubMed ID: 25335768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular delivery using poly(ortho esters).
    Heller J
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2053-62. PubMed ID: 16289431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(epsilon-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo.
    Mönkäre J; Hakala RA; Vlasova MA; Huotari A; Kilpeläinen M; Kiviniemi A; Meretoja V; Herzig KH; Korhonen H; Seppälä JV; Järvinen K
    J Control Release; 2010 Sep; 146(3):349-55. PubMed ID: 20558218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.